Delaware’s top economic development office has high hopes that the return of one of the most significant research and development tax deductions will spur a double down in investments from the state’s biopharmaceutical companies and manufacturers. When President Donald Trump signed the One Big Beautiful Bill Act (OBBBA), it once again allowed companies to deduct Already a subscriber? Log in

To continue reading this article ...

Subscribe to Delaware Business Times right now and get access to subscriber-only content like this article.

Plus get 24 issues of DBT via print or digital, special bonus issues, and discounted registration for our in-person events. Learn More and Subscribe Today

See Full Page